A Phase 2A Clinical Trial of EPI-743 (Vincerinone™) on Visual Function in Friedreich’s Ataxia Patients with Point Mutations

Research output: Other contributionOther

Original languageAmerican English
StatePublished - 2012

Disciplines

  • Epidemiology
  • Public Health

Cite this